Ethics
Versus Scientific Progress:
The
Benefits of Stem Cell Research Outweigh Risks
Zumana
Miyfa
ENG
21003, Section C
Professor
Nargiza Matyakubova
March 22, 2014
Ethics
Versus Scientific Progress:
The
Benefits of Stem Cell Research Outweigh Risks
How can one even imagine living with
an ailing disease, such as Parkinson’s, diabetes, or cancer? Well, these are only
some of the illnesses that numerous individuals must deal with on a daily
basis. Would it be wrong for scientists to be allowed to conduct groundbreaking
research that could treat these diseases more effectively and lead to possible
cures? The clear answer to this question is absolutely not. It should be
permissible for researchers to conduct stem cell research because the advances
made in the field of medicine outweigh the risks and ethical dilemma concerning
this type of research.
What
is Stem Cell Research?
The controversial debates over stem
cell research began when stem cells were first discovered in the late 1900s. According
to Haldeman-Englert (2012), “A stem cell is generic cell that can make copies
of itself indefinitely” (p. 1). These unique cells are fundamental for the
revolutionary type of research known as “stem cell research” because they can
multiply at a quick rate and create specialized cells for various types of
tissues that the human body needs, such as brain tissue, heart muscle, and
liver tissue. The cells can be stored away and used when specialized cells are necessary
as well.
There
are also two basic types of stem cells: embryonic stem cells and adult stem
cells. Embryonic stem cells (ES cells) are “taken from aborted fetuses or
fertilized eggs that are left over from in vitro fertilization (IVF)”
(Haldeman-Englert, 2012, p. 1). The ES cells are useful for research and
medical purposes because they can produce cells for almost any part of the
body. On the other hand, adult stem cells are specific to certain cell types
and cannot be used as effectively for conducting research. Adult stem cells can
be found in both adults and children, but they consist of blood, intestine,
skin, and muscle cell types (Badge, 2001, p. 85). Therefore, adult stem cells
are not as versatile as embryonic stem cells, which can lead to cures for
various
diseases.
Two significant breakthroughs have
emerged as a result of stem cell research, and it is necessary for further
research to be conducted in order to make even more discoveries. Those
breakthroughs are “animal cloning by Ian Wilmut, Keith Campbell and
colleagues and the derivation of pluripotent human embryonic stem (ES) cells by
Jamie Thomson and co-workers” (Badge,
2001, p. 88). Animal cloning is an advancement in stem cell research
because if animals could be cloned, then there is potential for human body
parts and organs to be cloned and used to cure individuals who have heart
problems or kidney failure. Thomson’s discovery of pluripotent human ES cells
is also essential because pluripotent embryonic stem cells are found in
implanted embryos, fetuses, and developed organisms; these are the cells that
have the ability to become all cell types. Therefore, his research on ES cells
is the building block for future stem cell research since the pluripotent cells
can form various tissues that the body needs.
Furthermore, pluripotent stem cells can
reduce the human body’s natural rejection of certain cells and organs, which
may occur during surgical procedures. The “combining [of the animal cloning
process and pluripotent ES cells discovery] in the process of ‘therapeutic cloning’,
whereby ES cells could be derived from a patient’s cell,” solves the dire “problems
of immune rejection” (Badge,
2001, p. 88). Therapeutic cloning can result in the curing many diseases
because the human body does not reject the cloned embryonic stem cells whereas
the body often rejects cells if organs are donated from other individuals. The
ES cells are also “one of the easiest types to grow [and they have] the
greatest potential” (Badge, 2001, p. 89). Therefore, the embryonic stem cells
are the most necessary for research because they are the ones that will be able
to treat and cure cell-related illnesses.
Benefits
of Stem Cell Research
As a result of ethical dilemmas,
stem cell research has been conducted primarily on mice, but ES cell research
has significantly more benefits when human embryos are used. According to
Solter (2006), “The derivation of the first human ES cell lines and
human embryonic germ-cell lines lagged significantly behind their mouse counterparts”
(p. 324). Cell research is primarily conducted on mice since it is difficult
for researchers to obtain human embryos and fetuses for stem cell research due
to “potential legal problems and political and moral dilemmas” (Solter, 2006,
p. 324). However, in comparison to the results from the mice experiments, the
experiments conducted on human ES cells have shown that the human cells are
more applicable to the human body in terms of curing diseases that people
contract. Therefore, ES cell research is beneficial to people because specialized
cells that can be created from the stem cells have been proven to efficiently
treat Parkinson’s disease.
Embryonic
stem cells can effectively treat Parkinson’s disease since the illness affects
a person’s brain cells. Parkinson’s is a motor systems disorder, in which nerve
cells in the brain that are supposed to produce a chemical called dopamine
break down (Landis, 2012, p. 1). The absence of those nerve cells result in
tremor (excessive shaking or trembling), stiff muscles, slow movement, and/or problems
walking. Although there is no cure for this diseases, stem cell “tissue
transplantation has shown beneficial effects on some patients by long-term
reduction in clinical symptoms such as tremors, bradykinesia (slowness of
movement), akinesia (absence of normal movement) and postural impairment”
(Master, McLeod, and Mendez, 2007, p.4). Therefore, stem cell research directly
benefits those who suffer from the incurable Parkinson’s disease by reducing
the symptoms and discomfort that the illness causes and by decreasing the
amount of drugs that individuals need to take to treat Parkinson’s.
In addition
to treating Parkinson’s disease effectively, embryonic stem cell research can
also lead to progress in finding the cure for cancer. Huntly and Gilliland
(2005) are two researchers who have developed the theory that cancerous tumors
are results of “cancer stem cells,” which are cells in the embryo or fetus that
mutate and spread as tumors (p. 311). These two men noted the following:
A cancer stem cell would function in a
similar way to sustain the growth and spread of tumours while repopulating the
distinct cell types represented within the tumour. However, a cancer stem cell
would not be subject to the same intrinsic and extrinsic controls as normal stem
cells. This ‘cancer-stem-cell hypothesis’ represents a modern-day
interpretation of the proposal made by pathologists such as Rudolph Virchow and
Julius Cohnheim ~150 years ago that cancer results from the activation of
dormant embryonic-tissue remnants. (Huntly & Gilliland, 2005, p. 311)
This quote expresses how Huntly and Gilliland expanded upon
the original “cancer-stem-cell hypothesis” that Virchow and Cohnheim proposed
many years ago. The prevalent theory is that tumors develop from the cells that
mutate within the embryo. However, ES cell research can help determine exactly
which cells would be likely to cause cancer and discover potential ways to
change those cells. In terms of treating those who are battling cancer, stem
cells can be implanted in order to replace the tumors that must be removed and
the human body would not be as susceptible to rejecting those cells. Further
research could ensure that those stem cell transplants prevent cancer from
returning in the long run.
Risks
of Embryonic Stem Cell Research
One major risk of stem cell research
is that it puts women’s health in danger because of the medicine they receive
after donating ova. Beeson (2006) stated that, “young women are being
asked to donate or sell their ova, not only for use in fertility clinics, but
increasingly for non-clinical use in experimental cloning research” (p. 1). When
women donate or cell their eggs for experiment research, they are given
hormonal drugs that may have short-term and long-term effects on their health.
However, this issue can easily be resolved through better regulation of the
hormonal drugs that are administered to the ova donors. Women could also be
properly advised
regarding how those drugs will affect their bodies, and the
option of donating or selling ova should be determined by those women solely
since they have the freedom to do what they want with their own bodies.
Ethical
Dilemma Regarding Stem Cell Research
A common misconception is that stem
cell research is unethical because it goes against religious doctrines in which
God or a higher power is meant to create human life. However, the utilizing of
stem cells to cure illnesses does not infringe on religion at all. Scientists
are not creating new life; they are simply allowing embryonic stem cells to
duplicate and become specialized cells that can provide properly functioning
organs and body parts to those in need. It is certainly not ethical to make it
difficult for researchers to obtain embryonic stem cells since the research
studies would be benefitting the greater good, and religious practice promotes
helping those who are in need of aid.
Opponents of stem cell research also
argue that stem cell research promotes abortion, which is the same as
destroying potential human life. However, “the person principally responsible
for the experiment must also affirm his or her own knowledge of the sources of [the
embryonic] tissue […] and that the researcher had no part in the abortion
decision or its timing” (Shapiro, 1999, p. 31). This quote from the National
Bioethics Advisory Commission explains that ES cell research does not endorse
more abortions to take place because the researcher cannot have any say in the
choice to have an abortion. Therefore, it is incorrect for critics to assume
that stem cell research supports abortions. Embryonic stem cell research
actually makes proper use of aborted fetuses, which benefits society at large.
Another fallacy is that corporations
profit more from stem cell research than actual human beings do. According to
Beeson (2006), “[C]ollection of eggs for embryo cloning research is
being conducted in the context of an international race for dominance in […]
the production of embryonic stem cells and related products that may result in
substantial private financial gain while offering no therapeutic benefits” (p.
1). In reality, embryonic stem cell research and stem cell research in general is
not meant for corporations, public or private, to make financial gains. Even if
businesses do make a profit off of stem cell research, the public receives the
benefits in the long run; therefore, further research should be encouraged. On
the contrary, corporations and the federal government should also be providing
researchers with sufficient money in order to conduct further stem cell
research. Therefore, the argument that ES cell studies “result in substantial
private financial gain while offering no therapeutic benefits” is invalid
because of the overwhelming benefits that stem cell research may provide to
people.
The Bigger Picture
Ultimately, stem cell research leads
to greater benefits for individuals and for society while causing minimal harm
to women who donate their ova. The major benefits of embryonic stem cell
research are that it effectively treats malignant diseases, such as Parkinson’s
and cancer, and has the potential for scientists to clone the cells in order to
form fully functioning organs and body parts for people who need transplants.
Ethics should not deter scientists from conducting further ES cell research. In
fact, the world needs more researchers and egg cell donors who are willing to
contribute to innovative stem cell research and take the future of medicine
into their own hands.
References
Badge, R. (2001). The Future For
Stem Cell Research. In MRC National Institute for Medical
Research
Publications. Retrieved from
http://www.ibt.unam.mx/computo/pdfs/cursosviejos/bcelularII02/bcelular/Nature%20414_88%20stem-rev.pdf
Beeson, D. (2006). Egg Harvesting
For Stem Cell Research: Medical Risks And Ethical
Problems. In Reproductive BioMedicine Online
Publications. Retrieved from
http://download.journals.elsevierhealth.com/pdfs/journals/1472-6483/PIIS1472648310606475.pdf
Halderman-Englert, C. (2012). Stem
Cell Research. In University of Maryland
Medical Center
Publications Online. Retrieved from
http://umm.edu/health/medical/ency/articles/stem-cell-research
Huntly, B., and Gilliland, G.
(2005). Leukaemia Stem Cells And The Evolution Of Cancer-Stem-
Cell Research. In Nature Reviews: Cancer Publications and
PubMed Databases.
Retrieved from
http://groups.molbiosci.northwestern.edu/mayo/Paper%20pdfs/Huntly%20et%20al%20LSC.pdf
Landis,
S. C. (2012). NINDS Parkinson's Disease
Information Page. In National
Institute of Neurological Disorders and Stroke Publications Online. Retrieved
from
http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm
Master, Z., McLeod, M., and Mendez,
I. (2007). Benefits, Risks And Ethical Considerations In
Translation Of
Stem Cell Research To Clinical Applications In Parkinson's Disease. In
Journal of Medical Ethics Publications. Retrieved
from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2598267/
Shapiro, H. T. (1999). Ethical Issues in Human Stem Cell Research. Rockville,
MD: National
Bioethics Advisory
Commission Publications.
Solter,
D. (2006). From Teratocarcinomas To Embryonic Stem Cells And Beyond: A History
Of Embryonic Stem Cell Research. In
Nature Reviews: Genetics Publications and PubMed Databases. Retrieved from
http://mcb5068.wustl.edu/MCB/Lecturers/Huettner/Reading%20pdf/Solter06_NatureRevGenet.pdf
No comments:
Post a Comment